214 related articles for article (PubMed ID: 32680610)
1. Lessons from COVID 19: Are we finally ready to make opioid treatment accessible?
Krawczyk N; Fingerhood MI; Agus D
J Subst Abuse Treat; 2020 Oct; 117():108074. PubMed ID: 32680610
[No Abstract] [Full Text] [Related]
2. TIME TO REVISIT UNEVEN POLICY IN THE UNITED STATES FOR MEDICATION FOR OPIOID USE DISORDER DURING COVID-19.
Pena E; Ahmed S
Addiction; 2020 Oct; 115(10):1978-1979. PubMed ID: 32447795
[No Abstract] [Full Text] [Related]
3. Challenges of methadone maintenance treatment during the COVID-19 epidemic in China: Policy and service recommendations.
Jiang H; Su H; Zhang C; Liu X; Li R; Zhong N; Zhao M
Eur Neuropsychopharmacol; 2020 Jun; 35():136-137. PubMed ID: 32307223
[No Abstract] [Full Text] [Related]
4. Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic.
Cochran G; Bruneau J; Cox N; Gordon AJ
Subst Abus; 2020; 41(3):269-274. PubMed ID: 32697171
[TBL] [Abstract][Full Text] [Related]
5. Commentary on Hser et al. (2014): to retain or not to retain-open questions in opioid maintenance therapy.
Soyka M; Hillemacher T
Addiction; 2014 Jan; 109(1):88-9. PubMed ID: 24438113
[No Abstract] [Full Text] [Related]
6. Telemedicine's Role in Addressing the Opioid Epidemic.
Yang YT; Weintraub E; Haffajee RL
Mayo Clin Proc; 2018 Sep; 93(9):1177-1180. PubMed ID: 30097301
[No Abstract] [Full Text] [Related]
7. Commentary on Freelemyer et al. (2014): medication-assisted treatment in Africa-need is growing but response remains tepid.
Obot IS
Addiction; 2014 Jan; 109(1):33-4. PubMed ID: 24438111
[No Abstract] [Full Text] [Related]
8. "Should I stay or should I go?" Coming off methadone and buprenorphine treatment.
Winstock AR; Lintzeris N; Lea T
Int J Drug Policy; 2011 Jan; 22(1):77-81. PubMed ID: 20956077
[TBL] [Abstract][Full Text] [Related]
9. Rapid transitional response to the COVID-19 pandemic by opioid agonist treatment programs in Ukraine.
Meteliuk A; Galvez de Leon SJ; Madden LM; Pykalo I; Fomenko T; Filippovych M; Farnum SO; Dvoryak S; Islam ZM; Altice FL
J Subst Abuse Treat; 2021 Feb; 121():108164. PubMed ID: 33191004
[TBL] [Abstract][Full Text] [Related]
10. Opioid dependence - management in general practice.
Frei M
Aust Fam Physician; 2010 Aug; 39(8):548-52. PubMed ID: 20877747
[TBL] [Abstract][Full Text] [Related]
11. Use and misuse of opioid agonists in opioid addiction.
Modesto-Lowe V; Swiezbin K; Chaplin M; Hoefer G
Cleve Clin J Med; 2017 May; 84(5):377-384. PubMed ID: 28530896
[TBL] [Abstract][Full Text] [Related]
12. Methadone and buprenorphine treatments in patients with schizophrenia.
Dervaux A; Plancke L; Amariei A; Trouiller P; Tahon M; Martinetti MP; Naassila M; Cottencin O; Danel T
Schizophr Res; 2019 Jul; 209():286-288. PubMed ID: 31101511
[No Abstract] [Full Text] [Related]
13. Revising our attitudes towards agonist medications and their diversion in a time of pandemic.
Del Pozo B; Rich JD
J Subst Abuse Treat; 2020 Dec; 119():108139. PubMed ID: 33138924
[TBL] [Abstract][Full Text] [Related]
14. Medication-assisted therapy for opioid-dependent incarcerated populations in New Mexico: statewide efforts to increase access.
Trigg BG; Dickman SL
Subst Abus; 2012; 33(1):76-84. PubMed ID: 22263716
[TBL] [Abstract][Full Text] [Related]
15. Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the COVID-19 pandemic in England.
Aldabergenov D; Reynolds L; Scott J; Kelleher MJ; Strang J; Copeland CS; Kalk NJ
Int J Drug Policy; 2022 Dec; 110():103877. PubMed ID: 36265326
[TBL] [Abstract][Full Text] [Related]
16. Overview of Drugs Used to Treat Opioid Use Disorder.
Aschenbrenner DS
Am J Nurs; 2018 Aug; 118(8):25. PubMed ID: 30048283
[No Abstract] [Full Text] [Related]
17. Buprenorphine: a more accessible treatment for opioid dependence.
Flassing J
JAAPA; 2010 Sep; 23(9):40-3. PubMed ID: 20845653
[No Abstract] [Full Text] [Related]
18. Commentary on Cousins et al. (2016): Accumulating evidence on risk of mortality on and off opioid substitution treatment.
Hickman M; Macleod J; Degenhardt L
Addiction; 2016 Jan; 111(1):83-4. PubMed ID: 26669528
[No Abstract] [Full Text] [Related]
19. Buprenorphine Opioid Treatment During the COVID-19 Pandemic.
Luigi M; Luo M; Maes EJP
JAMA Intern Med; 2021 Aug; 181(8):1135. PubMed ID: 33843962
[No Abstract] [Full Text] [Related]
20. Buprenorphine Opioid Treatment During the COVID-19 Pandemic-Reply.
Nguyen TD; Saloner B; Stein BD
JAMA Intern Med; 2021 Aug; 181(8):1135-1136. PubMed ID: 33843947
[No Abstract] [Full Text] [Related]
[Next] [New Search]
